FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAinos, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AIMDW
Ainos, Inc. Stock AnalysisComprehensive stock analysis for Ainos, Inc. (AIMDW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAIMDW
AIMDW
Ainos, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AIMDW
  1. Home
  2. Stocks
  3. Ainos, Inc.

Ainos, Inc.

🇺🇸AIMDW•NASDAQ

Ainos, Inc.

🇺🇸AIMDW•NASDAQ
Market cap
$3.64M

Your view on AIMDW

Mkt Cap
$3.64M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Ainos, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Chun-Hsien Tsai
Headquarters
3050 Post Oak Boulevard, Houston, TX, US
Industry
Biotechnology
Sector
Healthcare
CEO
Chun-Hsien Tsai
Headquarters
3050 Post Oak Boulevard, Houston, TX, US
Description

Ainos, Inc. operates as a healthcare enterprise dedicated to advancing medical technologies. Its core focus involves developing both point-of-care diagnostic solutions and innovative, safe therapeutic options for various health conditions. The company's offerings include a COVID-19 antigen rapid test kit.

This is complemented by the Ainos' cloud-based test management App, a holistic platform comprising the rapid test kit, a personal mobile application, and an enterprise-level app. Ainos also provides a COVID-19 nucleic acid test.

Further technologies under development or offered include point-of-care testing for volatile organic compounds and Very Low-Dose Oral Interferon Alpha, an oral formulation of IFN-a with broad therapeutic potential. The firm is additionally developing a Synthetic RNA (SRNA) technology platform, with specific work being conducted in Taiwan.

Beyond these, Ainos' product line extends to women's health, pneumonia, the Ainos Pen, AI Nose, and a variety of other products. Originally incorporated in 1984, the company was formerly known as Amarillo Biosciences, Inc. and rebranded to Ainos, Inc. in May 2021. Its main operations are based in San Diego, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Ainos, Inc.. Starting points for Ainos, Inc.: EPS -$1.81, beta 2.17 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Ainos, Inc.. Trailing twelve-month EPS for Ainos, Inc. stands at -$1.81. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Ainos, Inc.. Ainos, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold AIMDW19 companies
Compare AIMDW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
APLIFAppili Therapeutics Inc.HealthcareBiotechnology$1.7M
AZTRAzitra, Inc.HealthcareBiotechnology$3.5M
BCTXZBriaCell Therapeutics Corp. WarrantHealthcareBiotechnology$239,235
CDTCDT Equity Inc.HealthcareBiotechnology$159,886
CLABFCore One Labs Inc.HealthcareMedical - Pharmaceuticals$500
REVBRevelation Biosciences, Inc.HealthcareBiotechnology$2.2M
VAXXVaxxinity, Inc.HealthcareBiotechnology$25,357
VRAXVirax Biolabs Group LimitedHealthcareBiotechnology$578,345
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
BCHMFBachem Holding AGHealthcareOTC$4.5B
BCLIBrainstorm Cell Therapeutics Inc.HealthcareOTC$6.8M
BCRXBioCryst Pharmaceuticals, Inc.HealthcareNASDAQ$1.9B
BCT.TOBriaCell Therapeutics Corp.HealthcareTSX$40.6M
BCTXBriaCell Therapeutics Corp.HealthcareNASDAQ$28.6M
BCYCBicycle Therapeutics plcHealthcareNASDAQ$218.0M
BDRXBiodexa Pharmaceuticals PlcHealthcareNASDAQ$189,830
BDTXBlack Diamond Therapeutics, Inc.HealthcareNASDAQ$82.2M
BEAMBeam Therapeutics Inc.HealthcareNASDAQ$2.2B
BETR.CNBetterLife Pharma Inc.HealthcareCNQ—
BETRFBetterLife Pharma Inc.HealthcareOTC$6.4M
Open Comparable Analysis
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Ainos, Inc. executives and directors. Shares of Ainos, Inc. have traded between $0.10 and $0.17 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Ainos, Inc.. Coverage tracks Ainos, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Ainos, Inc.

AIMDW AnalysisWeak
Past
1
Growth
1
Health
2
Profit
1
Value
1